IRCT20190324043105N1招募中2 期
Evaluation of the effectiveness of Edaravone compared with placebo in maintaining muscle strength, functional status, and quality of life in patients with amyotrophic lateral sclerosis
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Patients diagnosed as definite or probable ALS disease according to El Escorial Criteria
- •ALS patients who are graded as mild or moderate according to ALS Health State Scale.
- •The patient gets at least 2 points on all 12 items of the ALSFRS-R.
- •Forced vital capacity of at least 80% in spirometry.
- •Desire of the patient to participate in this study and Signing Written Informed Consent.
排除标准
- •Patients diagnosed as possible ALS disease according to El Escorial Criteria
- •ALS patients who are graded as severe or terminal according to ALS Health State Scale.
- •The patient can't get at least 2 points on all 12 items of the ALSFRS-R.
- •The patient administers another drug or herb for ALS treatment.
- •Unwillingness of patient to enter the clinical trial
研究者
相似试验
招募中
3 期
Efficacy of Edaravone with Thrombolysis in Acute Ischemic StrokeIRCT20210530051440N1Zanjan University of Medical Sciences244
已完成
不适用
Clinical study of the effectiveness of edaravone for the oxidative stress in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis (ALS)JPRN-UMIN000024854Okayama university20
尚未招募
3 期
Effectivnes of edaravone on ischemic strokeIschemic stroke.Cerebral infarctionIRCT20240224061102N1Yasouj University of Medical Sciences60
已完成
不适用
Safety and efficacy of Edaravone[Nichiiko] in patients with acute noncardiogenic brain embolismacute noncardiogenic brain embolismJPRN-UMIN000004597Takeshi Yamada20
已完成
3 期
Edaravone in COVID-19IRCT20200317046797N6Tabriz University of Medical Sciences30